Mout, Lisanne
Moll, Jan M.
Chen, Mingqing
de Morrée, Eleonora S.
de Ridder, Corrina M. A.
Gibson, Alice
Stuurman, Debra
Aghai, Ashraf
Erkens-Schulze, Sigrun
Mathijssen, Ron H. J.
Sparreboom, Alex http://orcid.org/0000-0003-2660-6644
de Wit, Ronald
Lolkema, Martijn P. http://orcid.org/0000-0003-0466-2928
van Weerden, Wytske M. http://orcid.org/0000-0003-0324-4804
Funding for this research was provided by:
Sanofi
Merck
Bayer
Servier
Janssen Pharmaceuticals
Article History
Received: 18 March 2020
Revised: 25 August 2020
Accepted: 10 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: All animal experiments were approved by the Animal experiment committee under the Dutch experiments on Animal Act (Erasmus MC ref. #17-867-02).
: The PCa cell lines PC346C-DCC-K and VCaP-DCC-E and PC339 will be made available for academic institutions under the Erasmus MC Biological Uniform Material Transfer Agreement.
: R.d.W.—Advisory role/speaker fees; Sanofi, Merck, Lilly, Roche, Bayer, Janssen, Clovis and research funding (Institutional); Sanofi, Bayer. M.P.L.—Advisory role/speaker fees; Incyte, Amgen, Janssen Cilag B.V., Bayer, Servier, Roche, Pfizer Sanofi Aventis Netherlands BV, Astellas and has received research funding (Institutional) from Sanofi, JnJ, Merck and Astellas. R.H.J.M.—has received research funding (Institutional) from Sanofi and Astellas. W.M.v.W.—has received research funding (Institutional) from Sanofi, Millennium, Janssen Pharmaceuticals and Servier.
: This study was financially supported by an unrestricted grant by Sanofi; however, Sanofi was not involved in the design and interpretation of this study.